P30 CA014520-37/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2009	12
2010	13
2011	18
2012	2
2013	1
2024	0

1

Wheeler DL, Iida M, Dunn EF. Wheeler DL, et al. Oncologist. 2009 Jul;14(7):667-78. doi: 10.1634/theoncologist.2009-0009. Epub 2009 Jul 6. Oncologist. 2009. PMID: 19581523 Free PMC article. Review.

2

The nuclear epidermal growth factor receptor signaling network and its role in cancer.

Brand TM, Iida M, Li C, Wheeler DL. Brand TM, et al. Discov Med. 2011 Nov;12(66):419-32. Discov Med. 2011. PMID: 22127113 Free PMC article. Review.

3

A microfluidic cell concentrator.

Warrick J, Casavant B, Frisk M, Beebe D. Warrick J, et al. Anal Chem. 2010 Oct 1;82(19):8320-6. doi: 10.1021/ac101866p. Anal Chem. 2010. PMID: 20843010 Free PMC article.

4

The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patients.

Kruser TJ, Traynor AM, Wheeler DL. Kruser TJ, et al. Expert Opin Investig Drugs. 2011 Feb;20(2):305-7. doi: 10.1517/13543784.2011.550873. Epub 2011 Jan 5. Expert Opin Investig Drugs. 2011. PMID: 21204748 Free PMC article. Review.

5

Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA).

Basu HS, Mahlum A, Mehraein-Ghomi F, Kegel SJ, Guo S, Peters NR, Wilding G. Basu HS, et al. Cancer Chemother Pharmacol. 2011 Mar;67(3):705-15. doi: 10.1007/s00280-010-1364-3. Epub 2010 May 30. Cancer Chemother Pharmacol. 2011. PMID: 20512578 Free PMC article.

6

Validating cancer drug targets through chemical genetics.

Burkard ME, Jallepalli PV. Burkard ME, et al. Biochim Biophys Acta. 2010 Dec;1806(2):251-7. doi: 10.1016/j.bbcan.2010.08.002. Epub 2010 Aug 12. Biochim Biophys Acta. 2010. PMID: 20708654 Free PMC article. Review.

7

The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.

Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. Soto BL, et al. Cancer Immunol Immunother. 2011 May;60(5):731-8. doi: 10.1007/s00262-011-0971-0. Epub 2011 Feb 22. Cancer Immunol Immunother. 2011. PMID: 21340652 Free PMC article.

8

A phase I and pharmacokinetic study of oral lapatinib administered once or twice daily in patients with solid malignancies.

Burris HA 3rd, Taylor CW, Jones SF, Koch KM, Versola MJ, Arya N, Fleming RA, Smith DA, Pandite L, Spector N, Wilding G. Burris HA 3rd, et al. Clin Cancer Res. 2009 Nov 1;15(21):6702-8. doi: 10.1158/1078-0432.CCR-09-0369. Epub 2009 Oct 13. Clin Cancer Res. 2009. PMID: 19825948 Free PMC article. Clinical Trial.

9

Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.

Rocque G, Onitilo A, Engel J, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME. Rocque G, et al. Breast Cancer Res Treat. 2012 Jan;131(2):713-21. doi: 10.1007/s10549-011-1862-y. Epub 2011 Nov 8. Breast Cancer Res Treat. 2012. PMID: 22065290 Free PMC article.

10

Expression of the active Notch1 decreases MTC tumor growth in vivo.

Jaskula-Sztul R, Pisarnturakit P, Landowski M, Chen H, Kunnimalaiyaan M. Jaskula-Sztul R, et al. J Surg Res. 2011 Nov;171(1):23-7. doi: 10.1016/j.jss.2011.03.035. Epub 2011 Apr 13. J Surg Res. 2011. PMID: 21571316 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year